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Background: The sodium/iodide cotransporter solute carrier family 5 member 5 (SLC5A5) is found in the basolateral cell membrane of 
thyroid follicular epithelial cells as a sodium iodide symporter. It helps in the secretion of triiodothyronine (T3) and tetraiodothyronine (T4). 
Polymorphisms in SLC5A5 result in hypothyroidism. The aim of the study is to estimate the frequency of rs7250346, a single nucleotide 
polymorphism (SNP) associated with thyroid disease, in a Saudi population and to compare it to other populations. Methods: Two hundred 
and forty Saudi patients from King Faisal Specialist Hospital and Research Centre provided samples for the genetic analysis. Samples were 
genotyped for target SNPs by real time polymerase chain reaction (PCR), and the resultant rs7250346 frequency in the Saudi population 
was compared to other populations using HapMap. Results: Out of the 240 Saudi samples, 64% had C genotype and 35% had G genotype 
in the rs7250346. Conclusion: The Saudi frequency of the rs7250346 SNP of SLC5A5 differs from that of European, Chinese, Japanese, or 
Sub-Saharan populations in HapMap (http://hapmap.org).
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Introduction
The nature of many diseases and their occurrence vary from 
one population to another according to their genetic back-
grounds. These genetic variations are influenced by mutations, 
natural selections, migrations and genetic drifts.1 When the 
genomic sequence is altered in less than 1% of population, 
compared to the referenced sequence, the mutation will occur. 
However, if the alteration on a specific genome is present in 
≥1% of population, the polymorphism becomes the source of 
this variation. Moreover, the most common genetic variation in 
humans is caused by single nucleotide modification. The Single 
Nucleotide Polymorphism (SNP) presents if ≥1% of population 
possess a change in a nucleotide.2 Determining the SNP is use-
ful to explain the susceptibility of an individual to disorders, 
vaccines and medications. Some genetic diseases follow simple 
patterns of transmissions (simple Mendelian diseases), which 
are caused by a single SNP. Nonetheless, for complex genetic 
diseases, other factors in addition to SNPs play roles to mani-
fest diseases such as the environmental factor.3
The SLC5A5 gene encodes the sodium iodide symporter. It is 
located at 19p13.11. The sodium-iodide symporter (NIS) is an 
integral membrane glycoprotein with 634 amino acids and 
molecular weight of 69K Da, it consists of 15 exons spanning 
23202bp and 13 transmembrane domains and an extracellular 
N-terminal. SLC5A5 is found in the basolateral cell membrane 
of thyroid follicular epithelial cells.4 In 1996, it was sequenced 
from rats followed by human thyroid,5 while the description of 
exon-intron organization occurred in 1997.6
Triiodothyronine (T3) and tetraiodothyronine (T4) are thyroid 
hormones which are synthesized when SLC5A5 concentrates 
I- in the thyroid.7 The iodine can be taken with a trace amount 
from food supplement. It can be used for the diagnostic scinti-
graphic imaging or as radio iodide therapy when SLC5A5 accu-
mulate iodide in the thyroid gland.8 NIS is organified into the 
thyroid hormone precursor thyroglobulin by thyroid peroxidase 




). It's regulated by 
thyroid stimulating hormone (TSH) under control of the hypo-
thalamic-pituitary axis.9
Polymorphisms in SLC5A5 have also been related to a con-
genital iodide transport defect (ITD), which can cause hypo-
thyroidism.10 The c.1060A>C variant associated with congeni-
tal hypothyroid goiter leads to failure of iodide transport.11,12 
Homozygosity for the same variant in nucleotide 1060 (eu-
thyroid goiter) will lead to a defect in iodide transport.13,14 The 
c.1146C>G variant (hypothyroid goiter) will lead to NIS without 
detectable bioactivity and low expression,15 and the c.1629G>A 
variant (congenital hypothyroid goiter) will give minimal iodide 
uptake.16 A 6192bp deletion in exon 3-7 (congenital hypothyroid 
goiter) will result in total failure of iodide transport.17 This SNP 
of SLC5A5 was studied because it has previously been shown to 
have a significant association with thyroid diseases.18 In addi-
tion, it is an intron that is identified as rs7250346, and located 
on chromosome 19:17893553, the polymorphism is a C/G trans-
version substitution. Given that there are higher incidences of 
thyroid diseases in the Saudi population,19,20 it is plausible that 
some of this difference may stem from genetic polymorphisms. 
The different distribution of the genotypes may give some ex-
planations of the incidence of thyroid related diseases in this 
population. The aim of this study is to measure the frequency 
of the rs7250346 SNP in SLC5A5 in the Saudi population and 
compare it with other populations.
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Methods
Study Population
A cohort of 240 healthy Saudi individuals from the outpatient 
clinics, who came for routine check-ups or following mild con-
ditions that are not interfere with the purpose of the study 
such as controlled diabetes mellitus, at King Faisal Specialist 
Hospital and Research Centre was admitted to the study. In-
dividuals who had normal blood, biochemistry, hormones (in-
cluding TSH) and coagulation laboratory results were recruited. 
Patients who had liver impairment, renal insufficiency, mental 
instability or who were on multiple medications were excluded. 
DNA Isolation
Five milliliters of blood was sampled from each participant af-
ter obtaining their written consent. DNA was isolated using the 
Puregene DNA isolation kit according to manufacturer’s proto-
col (Qiagen Sciences, Maryland, USA). Briefly, erythrocytes were 
lysed in RBC lysis buffer, and the proteins were removed by 
precipitation in TCA buffer. The DNA was subsequently isolated 
by precipitation in alcohol, quantified and stored at -80°C if not 
required immediately. 
Real-Time PCR Genotyping
Samples were genotyped for target SNPs by real time PCR using 
the 7900HT Sequence Detection System (ABI, Foster City, CA, 
USA).  Primers and TaqMan probes were designed using the 
Primer Express software V2.0 (ABI, Foster City, CA, USA) and 
obtained from Applied Biosystems (Warrington, UK).  The fluo-
rogenic probes, bearing a suitable reporter dye on the 5' – end 
and a quencher dye on the 3' –end, hybridize to the specific 
sequence to be amplified by the PCR primers.  The quencher 
prevents fluorescent emission from the reporter dye when the 
probe is intact. When the probe is cleaved by the polymerase 
exonuclease activity in the extension phase of PCR, there is 
increased fluorescent emission from the reporter which is no 
longer in close proximity to the quencher.
One probe, for allele 1, is labeled with VIC dye and the other, 
for allele 2, with FAM dye at the 5' –end. Serial dilutions of the 
probes were run to determine the optimal working concentra-
tion.  For each well of a 96-well reaction plate a 25 μl reaction 
was prepared by mixing 5 μl containing 50ng DNA, 12.5 μl of 
2x universal mix (Eurogentec, liege Science Park, 4102 Seraing, 
Belgium), 1.25 μl of 20x probe Assay mix and 6.25 μl of 1x Tris 
EDTA buffer. Three no-template controls were included for each 
plate. The thermal profile for amplification was a 1st cycle at 
50°C for 2 minutes, and 95°C for 10 min, followed by 40 cycles 
of 94°C for 15sec, and 60°C for 30 sec. The plate wells were 
scanned for fluorescence resonance energy transfer (FRET) sig-
nal in the 7900HT sequence detection system, and the data 
analyzed using SDS 2.0 software (ABI, Foster City, CA, USA). Ex-
cel program was used to analyze the data. The Saudi genotypes 
of rs7250346 SNP in SLC5A5 were compared with other popu-
lations, particularly, Sub-Saharan Africans, Chinese, Japanese 
and Europeans, which are included in the HapMap project. This 
project studied 11 populations in three phases. The three co-
llections consist of 1,301 samples in addition to the original 
270 samples used in the first two phases. Furthermore, this 
resource was aimed to identify the common patterns of human 
DNA sequence variation. According to the HapMap samples, all 
participants provided informed consents.
Results
In this study, the total population included 240 patients from 
the outpatient clinics at King Faisal Specialist Hospital and Re-
search Centre, comprised of 146 (61%) females and 94 (39%) 
males. The mean age of the subjects was 44+/-15 years. Two 
alleles were examined for each subject to create a total of 480 
alleles samples. Out of 480 Saudi alleles, 308 (64%) had a C 
genotype for the rs7250346 SNP in SLC5A5 and 164 (35.4%) had 
a G genotype (Figure 1).
Discussion
The goal of the study was to determine the differences between 
Saudi and other populations for the rs7250346 SNP in SLC5A5. 
However, a possible limitation of this study is that NIS was 
the only SNP analyzed in this population. It is an intron that 
can lead to interesting molecular biology discussion because it 
varies between different geographical populations and it is as-
sociated with different conditions. This SNP is associated with 
the thyroid gland, and some variants are linked to functional 
abnormalities. Some studies suggested that certain polymor-
phisms might lead to hypothyroidism,10 congenital hypothyroid 
goiter,11 and hypothyroidism.15  Nevertheless, studies on NIS 
are scarce and there is insufficient data to link a variant of this 
gene to diseases in certain populations. 
In the Saudi population, the incidence of thyroid cancer increa-
sed dramatically between 2000 and 2010 where it was respon-
sible for 9% of all malignancies in one Saudi hospital, compared 
to 2.9% in U.S. In addition, in King Faisal Specialist Hospital & 
Research Centre, it became the second most common cancer 
among females.19,20 For that reason, this study sought to inves-
tigate how the Saudi SLC5A5 differs from other populations, 
which may help researchers understand if this SNP has a role in 
the high incidence of other thyroid disorders, including thyroid 
cancer, in this population. 
This study demonstrated that there is a marked difference 
between the Saudi allele frequency and other populations for 
SNP rs7250346. Figure 1 shows the genotype in Saudi popula-
tion (C=64% and G=35.4%), Also it represents the same gene 
in HapMap (http://hapmap.org) with other different popula-
tions, namely, European, Japanese, Chinese and Sub-Saharan 
African, which are not similar to the Saudi population gene. In 
the Chinese population, 100% possessed the C genotype while 
it occurred in 97% of the Japanese population. The G genotype 
occurred in 20% Europeans and C genotype in 80%. The distri-
bution of the genotypes in Sub-Saharan African is C=32.5% and 
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G=67.5%. The variations in the prevalence of thyroid abnorma-
lities and how they are associated with genetic polymorphisms 
can be observed if congenital hypothyroidism is taken as an 
example, where it is correlated with the hereditary in 15% of 
the cases. Importantly, it was found that defects in NIS, which 
includes thyroid hormone transport abnormalities, was consi-
dered as one of the causes of this illness.21 
According to a Chinese screening study, the prevalence of con-
genital hypothyroidism is increasing, where 6,505 of neonates 
were diagnosed as congenital hypothyroidism out of 13,229,242 
Chinese newborns from 1985 to 2006.22 Also, a New York scree-
ning program from 2000 to 2003 published that congenital 
hypothyroidism differed among four ethnicities, and it showed 
that Caucasian and Black infants had lower incidence of conge-
nital hypothyroidism when compared to Hispanic and Asian po-
pulations. Congenital hypothyroidism was diagnosed in 1/1815 
births among Caucasian infants, 1/1902 of Black infants, 1/1559 
of Hispanic infants and 1/1016 of Asians infants.23 
Unfortunately, there are not enough studies to determine an 
ethnic pattern for SLC5A5 in the Saudi population. Further stu-
dies are warranted to discover the gene differences between 
populations. Furthermore, research into the genetic composi-
tion of the Saudi population is needed to provide an appro-
priate estimation of gene patterns. Studying this SNP may 
have some implications for future research, clinical practice 
and public health policy. Saudi SLC5A5 may allow researchers 
to investigate its association with hypothyroidism, which may 
prevent unnecessary prescription of Thyroxin to treat an idio-
pathic condition, or even prevent it in the first place. Moreover, 
finding how Saudi genotypes differ from other ethnic groups 
may provide some clues about why thyroid abnormalities are 
widely diagnosed in the Arabia Peninsula.
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